EXAMPLE REPORT ONLY Contact AMS Biotechnology for current donor specific information

Similar documents
Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

1.) 3 yr old FS Siamese cat: 3 day history of lethargy, anorexia. Dyspneic, thin, febrile.

REGISTRATION FORM 1 / 2

HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM

Tables of Normal Values (As of February 2005)

Notes for the 2 nd histology lab

B. PANITUMUMAB DOSE LEVEL 0 No dose reduction 1 Level -1 2 Level Other, specify in comments for this cycle

ERROR CORRECTION FORM

BLOOD PHYSIOLOGY. White Blood Cells (WBC) Dr Nervana Mostafa

COMPANY OR UNIVERSITY

HOVON 141 CLL. Version 3, 25JUL2018. Table Required investigations at entry, during treatment and during follow up.

FBC interpretation. Dr. Gergely Varga

Morfologia normale e patologica

SMALL ANIMAL SOFT TISSUE CASE-BASED EXAMINATION

MEDICAL HISTORY. 23-Jan-2018 to 23-Jan VCA Miller-Robertson Animal Hospital 8807 Melrose Ave, Los Angeles, CA (310)

CLINICAL USE OF CELLULAR SUBPOPULATION ANALYSIS IN BM

Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and

XN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016

SydPath Reference Intervals for Clinical Trials (Contract Pathology Unit) Unauthorised Copy

CIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed:

Hematology 101. Rachid Baz, M.D. 5/16/2014

REFERENCE INTERVALS. Units Canine Feline Bovine Equine Porcine Ovine

MORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

Provided by MedicalStudentExams.com NORMAL LABORATORY VALUES

Understanding Blood Tests

Biology 218 Human Anatomy. Adapted form Martini Human Anatomy 7th ed. Chapter 20 The Cardiovascular System: Blood

بسم هللا الرحمن الرحيم

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

Blood Cell Identification Graded

HYPERCALCEMIC GOLDEN RETRIEVER

Leukocytosis - Some Learning Points

Case #1. 65 yo man with no prior history presented with leukocytosis and circulating blasts: Bone marrow biopsy was performed

NEW RCPCH REFERENCE RANGES-

Supplementary materials

NORMAL LABORATORY VALUES FOR CHILDREN

SMALL ANIMAL SOFT TISSUE CASE- BASED EXAMINATION

2013 AAIM Pathology Workshop

Flow Cytometry. Leukemia and Myelodysplastic Syndromes. Bone Marrow Aspirate and Biopsy

Rapid Laboratories In House Tests

Bone marrow aspiration as the initial diagnostic tool in the diagnosis of leukemia - A case study

Blood = Fluid connective tissue. Formed elements in plasma.

Test Result Reference Range Flag

PAML interface maintenance bulletin 8/12/2013 ATTN: INTERFACE DATA MANAGER

By Dr. Mohamed Saad Daoud

Australian and New Zealand College of Veterinary Scientists. Membership Examination. Small Animal Medicine Paper 1

Blood Cells Med Terms Quiz

BASIC METABOLIC PANEL

Objectives. Challenging Case Studies in Laboratory Diagnosis: A Focus on WBC and Hepatic Testing

Hemopoiesis and Blood

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Hematopathology Case Study

Chapter 4. M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University.

Hamilton Regional Laboratory Medicine Program

Chronic Myelomonocytic Leukemia with molecular abnormalities SH

BIOCHEMISTRY of BLOOD

Hematopathology Case Study

Inspector's Accreditation Unit Activity Menu

Hematology Revision. By Dr.AboRashad . Mob

Hamilton Regional Laboratory Medicine Program

VETERINARY HEMATOLOGY ATLAS OF COMMON DOMESTIC AND NON-DOMESTIC SPECIES COPYRIGHTED MATERIAL SECOND EDITION

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

10 Essential Blood Tests PART 1

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

BC Biomedical Laboratories Adult Reference Ranges

Juvenile Myelomonocytic Leukemia (JMML)

Chapter 21 Outline. General Composition and Functions of Blood Blood Plasma Formed Elements in the Blood Hemopoiesis: Production of Formed Elements

Flow cytometry leukocyte differential : a critical appraisal

Flow Cytometry. Bone Marrow Aspirate and Biopsy. Leukemia and Myelodysplastic Syndromes

The Immune System. A macrophage. ! Functions of the Immune System. ! Types of Immune Responses. ! Organization of the Immune System

Collected: , PM Sent: , PM Received: , PM Preliminary: , PM. Notification Status: COMPREHENSIVE DIAGNOSIS

Extramedullary precursor T-lymphoblastic transformation of CML at presentation

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes.

WBCs Disorders. Dr. Nabila Hamdi MD, PhD

GRADING CRITERIA for CMS Regulated Analytes

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE

Blood Physiology. Rodolfo T. Rafael, M.D.,CFP

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal/

Please contact the Client Services Team if you require further information.

FLOW CYTOMETRIC ANALYSIS OF NORMAL BONE MARROW

Cycle 1-6 (28 Days) Days 15&16 1&2 8. (±2 Days) (±2 Days) (±7 Days) (+7 days) X X X X X X X

CLL13 trial of the GCLLSG/ The GAIA Trial Page 23 of 113 IV. Baseline assessments at screening (for all patients)

PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert.

Leukemia and Myelodysplastic Syndromes

Clinician Blood Panel Results

ENROLLMENT CONFIRMATION

Leukemia and Myelodysplastic Syndromes

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017

Hematology Unit Lab 2 Review Material

Cytochrome-C (rat, mouse) forward GGAGGCAAGCATAAGACTGG. mouse hexokinase 2 gene, intron 9 reverse GGGAACACAAAAGACCTCTTCTGG

screening procedures Disease resistant to full-dose imatinib ( 600 mg/day) or intolerant to any dose of imatinib

Bone Marrow Pathology. Part 1. R.S. Riley, M.D., Ph.D.

BLOOD. Dr. Vedat Evren

A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century. Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter

H.6.G.2 Non-MAC Studies

Comparison of VACUETTE Heparin Gel Tubes for Common Chemistry Analytes

Multiple Myeloma 101: Understanding Your Labs

Leukocyte Disorders. Dr Alauldeen Mudhafar Zubair

Transcription:

EXAMPLE REPORT ONLY Contact AMS Biotechnology for current donor specific information NAME DIAGNOSIS PROTOCOL OF EVALUATION for Chronic Lymphatic Leukemia (CLL) GENERAL INFORMATION (ALL information required!!) 34-028/0210_ CLL INFORMED CONCENT (signature) STAGE Rai-Binet Received _02/02/2010_ (mm/dd/yyyy) SEX M F Date of birth 04/01/1962 (mm/dd/yyyy) Unknown Ethnicity Caucasian (White) Date of First Diagnosis 01/2010_ (mm/yyyy) Age at beginning of disease 47 (years) Duration of the Disease From beginning of disease to date of CRF completion: _1_(months) Date of blood drawing: 02/02/2010 (mm/dd/yyyy) Test was performed on the same day Y N Date of BM drawing: (mm/dd/yyyy) Test was performed on the same day Y N WBC count (10 9 /L) 25 10 25 < 10 Peripheral blood CD 19+ count 60 <60 HIV 1/2 & Hepatitis B/C tests Negative Positive SAMPLE IS NOT ACCEPTED Previous treatment Yes (page.2) No Clinical information CLINICAL DATA Lymphocytosis Yes No Lymphadenopathy Hepatosplenomegaly Yes No Yes No Specify_neck, subclavia, inguinalis, axillaries Organ(s) involvement Yes No Specify Other: Page # 1 of 5

Current Concomitant diseases Diagnosis Date (month/ year) Physical examination Endotoxicosis Yes No Activity: Malnutrition (10 per year) Yes No Fever (month, a/b resistance) Yes No Other 0 the usual activity 1 activity is decreased 2 <50 of daytime in bed 3 >50 of daytime in bed 4 recumbent patient, it cannot attend itself _1 Score THERAPY No previous Therapy No information available Date of Diagnosis (mm/dd/yyyy) 01/2010 Medication Dose Date Therapy Effect of the treatment Positive Negative None Resistance to the therapy No Yes Complications of the therapy No Yes specify Page # 2 of 5

CLINICAL TESTS * If normal values (Normal Range) of your laboratory differ from listed bottom, please write normal values in brackets after data of the test (parameter). 1. Clinical blood test Machine Manual Value Normal Range Units Hemoglobin (HGB) 118 130 160 g/l Red Blood Cell Count (RBC) 4.03 4 5.1 10*12/L Platelets 289 180 320 10*9/L White Blood Cell Count 4.9 4-8.8 10*9/L 2. Biochemistry Value Normal Range Units Potassium (К+) 3.5 5.5 Mmol/L Calcium (Са+) 2.2-2.7 Mmol/L AST (АСТ) 12 5 40 U/L ALT (АлАТ) 11 5 40 (< 0.64) U/L (Mmol/L) Bilirubin 17.9 Up to 20 µmol/l Creatinine 55 0.04 0.11 Mmol/L ESR 24 1 10 mm/h Uric Acid 140 M: 0.2 0.41 F: 0.14 0.34 Mmol/L Machine WBC differential Manual Glucose 5.7 3.9-5.8 Mmol/L Total protein 69 64 83 g/l Albumin 45 35 50 g/l Blasts 0 Neutrophils (сегм) 56 55-70 Band cells (пал/яд) 0 Lymphoblasts 0 Prolymphocytes 0 Lymphocytes 38 20-40 Monocytes 8.6 2-8 Eosinophils (Эо) 0 1-4 Basophils (Б) 1.6 0.5-1.0 Plasma cells 0 0 Smear cells Globulin 2.3-3.4 g/dl a1 Globulin 1-3 g/l a2 Globulin 6-10 g/l β Globulin 7-11 g/l IgG IgA IgM Lactatedehydro genase (LDH) Alkaline phosphatase (ALP) β2- Microglobulin (β2m) 121 565 1765 (8.8 19.7) 85 385 (0.9 3.9) 55 375 (0.5 2.0) 6,6-26 43 35-104 0 3 µg/ml Page # 3 of 5

3. Urine test Date (mm/dd/yyyy) 02/03/2010_ Value Normal Range Units Specific gravity 1015 1005-1035 Protein - none g/l Leukocytes 2-4 0-5 RBC - 0-5 Epithelial - 0-5 Cylinders - none Bacteria - none Salt - none Other: 4. Caryotype: Date (mm/dd/yyyy) / / _ 5. Bone Marrow aspirate differential Cells Normal range Units Undifferentiated blast cells 0.4 (0.1-1.1) Myeloblasts <5 (0.2-1.7) Promyelocytes (Progranulocytes) 0.4 1-8 (1.0-4.1) Myelocytes 7.8 5-15 (7.0-12.2) Metamyelocytes 3.8 15-25 (8.0-15.0) Band cells 4.6 (12.8-23.7) Neutrophils 13.8 (13.1-24.1) Total neutrophil lineage cells 30.4 (52.7-68.9) Mature eosinophilic myelocytes 0.5-3 (0-0.2) Eosinophilic metamyelocytes <1 (0.1-0.4) Eosinophils (0.4-5.2) Total eosinophil lineage cells 2.2 (0.5-5.8) Mature basophilic myelocytes <5 (0-0.2) Basopilic metamyelocytes <1 Basophils (0-0.3) Total basophil lineage cells 0.2 (0-0.5) Lymphoblasts (0-0.2) Prolymphocytes (0-0.2) Lymphocytes 3-20 (4.3-13.3) Total lymph. lineage cells 49.8 (4.3-13.7) Monoblasts (0-0.2) Monocytes 0.8 <5 (0.7-3.1) Plasmoblasts (0-0.2) Proplasmocytes (0.1-0.2) Plasma cells <1 (0.1-1.8) Total plasma lineage cells 0.4 Erythroid cells (0.2-1.1) Basophilic normoblasts (1.4-5.8) Polychr. normoblasts (8.9-16.9) Oxyphil normoblasts (0.8-5.6) Promegaloblasts Basophilic megaloblasts Polychr. megaloblasts Oxyphil megaloblasts Total erythr. lineage cells (normoblasts) Ratio of myeloid to erythroid cells (M/E ratio) 15.8 25-50 (14.5-26.5) 5.3 2.5:1 4:1 Megakaryocytes <5 Mast cells Stromal (RES) cells (0.1-0.4) Page # 4 of 5

Bone Marrow aspirate differential: 6. Immunophenotyping Blood Analysis : FACS IFA Immunofixation Date (mm/dd/yyyy) / / _ Bone marrow aspirate Analysis: FACS IFA Immunofixation Date (mm/dd/yyyy): 01/19/2010 _ Antigen Expression Antigens Coexpression Antigen Expression Antigens Coexpression () () () () CD45 CD5/ CD19 CD19 CD5/ CD38 CD3 CD19/ CD38 CD5 CD20/ CD23 CD38 CD10/ CD19 CD10 CD22/ CD43 CD23 CD20/ CD43 CD20 FMC7/ CD20 CD43 CD20/ CD25 FMC7 CD20/ CD22 CD25 / CD 19 CD22 / CD19 CD4/ CD8 CD4/ CD3 CD4 CD8/ CD3 CD8 сy CD3/Ki-67 cy CD3 cy CD79a/Ki67 CD79a in CD5/CD20 Ki-67 cy k/cy l CD45 CD5/ CD19 CD19 CD5/ CD38 CD3 CD19/ CD38 CD5 CD20/ CD23 CD38 CD10/ CD19 CD10 CD22/ CD43 CD23 CD20/ CD43 CD20 FMC7/ CD20 CD43 CD20/ CD25 FMC7 CD20/ CD22 CD25 / CD 19 CD22 / CD19 CD4/ CD8 CD4/ CD3 CD4 CD8/ CD3 CD8 сy CD3/Ki-67 cy CD3 cy CD79a/Ki67 CD79a in CD5/CD20 Ki-67 cy k/cy l Pan-expression CD20+CD5+CD23+ Signature (PI) Date Page # 5 of 5